欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0140/001
药品名称Normosang
活性成分
    • [No Active-Substance specified] 0.0 -
    • Human hemin 25.0 mg/ml
剂型Concentrate for solution for injection
上市许可持有人Orphan Europe SARL
参考成员国 - 产品名称France (FR)
Normosang
互认成员国 - 产品名称
    • Germany (DE)
      Normosang 25 mg / ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Normosang 25 mg/ml - Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
      Human Hemin Orphan Europe
    • Latvia (LV)
      Normosang 25 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Normosang 25 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      NORMOSANG
    • Hungary (HU)
      NORMOSANG 25 mg/ml koncentrátum oldatos infúzióhoz
    • Cyprus (CY)
      Normosang concentrate for solution for infusion 25mg/ml
    • Slovakia (SK)
      NORMOSANG 25 mg/ml
    • Czechia (CZ)
    • Slovenia (SI)
    • Malta (MT)
许可日期1999/05/05
最近更新日期2024/12/04
药物ATC编码
    • B06AB Heme products
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase